The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS III Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class III Guidelines
1. Theophylline and beta-adrenergic agonist agents are not recommended in patients with bronchospastic lung disease who develop AF. (Level of Evidence: C)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class III Recommendation 1 for patients with pulmonary hypertension should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. Beta blockers (sotalol, propafenone) and adenosine are not recommended in patients with obstructive lung disease who develop AF. (Level of Evidence: C)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class III Recommendation 2 for patients with pulmonary hypertension should be: CLASS I CLASS IIa CLASS IIb CLASS III